1Haas M. Histologic subclassification of IgA nephropathy: a clinic pathologic study of 224 cases. Am J Kidney Dis, 1997, 29: 829-242.
2Suzuki H, Sakuma Y, Kanesaki Y, et al. Close relationship of plasminogen activator inhibitor-1 4G/5G polymorphism and progression of igA nephropathy. Clin Nephrol, 2004, 62:173-179.
3Teresa Y, Peter P, Cheuk CS, et al. Association of plasminogen activator inhibitor-I 4G/4G genotype and type2 diabetic nephropathy in Chinese patients. Kidney lnt, 2000, 57: 632-638.
